“HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER”. 2019. Voprosy Onkologii 65 (3): 434-40. https://doi.org/10.37469/0507-3758-2019-65-3-434-440.